These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38404124)

  • 21. Parametric survival models for interval-censored data with time-dependent covariates.
    Sparling YH; Younes N; Lachin JM; Bautista OM
    Biostatistics; 2006 Oct; 7(4):599-614. PubMed ID: 16597670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Survival Models for Analyzing Prognostic Factors in Gastric Cancer Patients.
    Habibi D; Rafiei M; Chehrei A; Shayan Z; Tafaqodi S
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):749-753. PubMed ID: 29582630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generalized survival models for correlated time-to-event data.
    Liu XR; Pawitan Y; Clements MS
    Stat Med; 2017 Dec; 36(29):4743-4762. PubMed ID: 28905409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. geecure: An R-package for marginal proportional hazards mixture cure models.
    Niu Y; Wang X; Peng Y
    Comput Methods Programs Biomed; 2018 Jul; 161():115-124. PubMed ID: 29852954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The odd log-logistic generalized exponential distribution: Application on survival times of chemotherapy patients data.
    Fulment AK; Gadde SR; Peter JK
    F1000Res; 2022; 11():1444. PubMed ID: 38828230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing goodness of fit of parametric models for censored data.
    Nysen R; Aerts M; Faes C
    Stat Med; 2012 Sep; 31(21):2374-85. PubMed ID: 22714389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Personal exposure to mixtures of volatile organic compounds: modeling and further analysis of the RIOPA data.
    Batterman S; Su FC; Li S; Mukherjee B; Jia C;
    Res Rep Health Eff Inst; 2014 Jun; (181):3-63. PubMed ID: 25145040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multivariate network meta-analysis of survival function parameters.
    Cope S; Chan K; Jansen JP
    Res Synth Methods; 2020 May; 11(3):443-456. PubMed ID: 32125077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accounting for parameter uncertainty in the definition of parametric distributions used to describe individual patient variation in health economic models.
    Degeling K; IJzerman MJ; Koopman M; Koffijberg H
    BMC Med Res Methodol; 2017 Dec; 17(1):170. PubMed ID: 29246192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of hypertabastic survival model with other unimodal hazard rate functions using a goodness-of-fit test.
    Tahir MR; Tran QX; Nikulin MS
    Stat Med; 2017 May; 36(12):1936-1945. PubMed ID: 28173610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The partly parametric and partly nonparametric additive risk model.
    Hjort NL; Stoltenberg EA
    Lifetime Data Anal; 2023 Apr; 29(2):372-402. PubMed ID: 34698999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of backcalculation for estimation of the probability of progression from HIV infection to AIDS.
    Marion SA; Schechter MT
    Stat Med; 1993 Apr; 12(7):617-31. PubMed ID: 8511439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. General-Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations.
    Vervaart M; Aas E; Claxton KP; Strong M; Welton NJ; Wisløff T; Heath A
    Med Decis Making; 2023 Jul; 43(5):595-609. PubMed ID: 36971425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A bivariate power generalized Weibull distribution: A flexible parametric model for survival analysis.
    Jones MC; Noufaily A; Burke K
    Stat Methods Med Res; 2020 Aug; 29(8):2295-2306. PubMed ID: 31840558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parametric regression on cumulative incidence function.
    Jeong JH; Fine JP
    Biostatistics; 2007 Apr; 8(2):184-96. PubMed ID: 16636138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Finite Mixture Models, a Flexible Alternative to Standard Modeling Techniques for Extrapolated Mean Survival Times Needed for Cost-Effectiveness Analyses.
    Cislo PR; Emir B; Cabrera J; Li B; Alemayehu D
    Value Health; 2021 Nov; 24(11):1643-1650. PubMed ID: 34711365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cure fraction estimation from the mixture cure models for grouped survival data.
    Yu B; Tiwari RC; Cronin KA; Feuer EJ
    Stat Med; 2004 Jun; 23(11):1733-47. PubMed ID: 15160405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of Parametric Shared Frailty Models to Analyze Time-to-Death of Gastric Cancer Patients.
    Esayas Lelisho M; Akessa GM; Kifle Demissie D; Fikadu Yermosa S; Andargie SA; Tareke SA; Pandey D
    J Gastrointest Cancer; 2023 Mar; 54(1):104-116. PubMed ID: 35064523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.